INTRODUCTION
Foot and mouth disease (FMD) was officially recognised in Thailand in 1953, when an outbreak due to serotype A occurred. This was followed by recognition of type Asia 1 in 1954 and type O in 1957 (1, 2) . In 1956, the Royal Thai Government instituted an FMD control programme, which was complemented by appropriate statutes, and by the establishment of diagnostic, research and vaccine production facilities at the Foot and Mouth Disease Centre at Pak Chong, in 1958.
The control programme called for the establishment of a disease-free zone in the two southern regions (regions 8 and 9, comprising 14 provinces) through routine vaccination, movement controls and appropriate animal health measures. A further eight provinces in region 7, immediately north of the disease-free zone, were to be designated a buffer zone. FMD was eradicated from regions 8 and 9 and the disease-free zone declared in 1981. Vaccination in other areas of the country was principally performed in response to local outbreaks.
FMD vaccine production commenced at Pak Chong in 1960. Types A, O and Asia 1 viruses isolated in the Bangkok area were developed as vaccine strains for Frenkel vaccine production. The type A isolate was characterised by the World Reference Laboratory (WRL) in Pirbright (United Kingdom), and was assigned the subtype classification A 15 Thai/60 (3). This strain was referred to as A 15 Bangkok/1960 (A BKK/60) in Thailand.
In 1973, an outbreak of FMD occurred in the southern region of Thailand, subsequently spreading to Malaysia and Singapore. The locally-available A BKK/60 vaccine was unable to control this outbreak in southern Thailand. A virus isolated from this outbreak in Malaysia was classified by the WRL as subtype A 22 (5) . A contemporary isolate from southern Thailand was shown to be serologically distinct from A BKK/60 and was locally designated A 22 Songkla 1973 (A SKL/73) (8) . The outbreak was controlled and no subsequent isolations of A 22 were made from this region, which was declared an FMD-free zone in 1981.
Viruses isolated from outbreaks of FMD in central Thailand in the late 1970s and early 1980s were found to be more closely related to A SKL/73 than to A BKK/60 (6, 8) . This led to the development of vaccines based on locally-isolated strains. The most recent vaccine strain was designated A 22 Nakhon Pathom 1986 (A NPT/86). The Department of Livestock Development in Thailand initiated a policy to increase resources and efforts in FMD control in the 1990s. The control strategy includes the development of a new trivalent vaccine based on endemic viruses. A number of recent studies investigating outbreaks of FMD in Thailand have reported that endemic type A virus strains in Thailand are more closely related to the A 22 reference vaccine strain than to the A 15 vaccine strain (7, 9) . This study was undertaken to determine the relationships to the reference A 15 virus (A BKK/60) of a wide range of field viruses isolated between 1986 andl989, and taken from all regions where FMD was considered endemic. It was also hoped that some insight might be gained into the inter relationships between type A field viruses from Thailand. The comparison was undertaken using the two-dimensional serum microneutralisation test (SNT) (12) .
MATERIALS AND METHODS

Viruses
The reference vaccine viruses A BKK/60 (A 15 A selection of 82 field virus isolates was made, to cover all seven administrative regions of Thailand where FMD was endemic. Viruses were obtained from the diagnosis section of the FMD Centre in Pak Chong, and from the Northern Veterinary Research and Diagnostic Centre in Hang Chat. Viruses were initially typed by the complement fixation test (6) and/or enzyme-linked immunosorbent assay (15) . Primary isolation was made in tissue-culture monolayers of bovine thyroid, bovine kidney, goat kidney or BHK 21 cells. To conduct serum neutralisation tests, all viruses were adapted to growth in BHK 21 cells by four to six serial passages.
Antisera
Bovine antiserum to the A BKK/60 reference virus was provided by the assay section of the FMD Centre in Pak Chong. The serum was obtained after homologous challenge of cattle vaccinated with monovalent A BKK/60 vaccine during vaccine potency trials.
Antisera to the three reference viruses were produced in rabbits using the method of Have et al. (4) , modified by higher antigen levels and the use of live virus preparations. Briefly, rabbits received 40 ug of 146s antigen in Freund's complete adjuvant and were re-inoculated after 28 days with 20 ug of the same purified virus in either 50% incomplete Freund's adjuvant or phosphate-buffered saline with 0.025 mg/ml of saponin.
Determination of serological relationships
Isolates were assessed for their serological relationship to one or more of the reference viruses by the calculation of r values (11) , where:
titre of reference antiserum against test virus r = titre of reference antiserum against homologous virus
The titre of an antiserum against a particular test virus was determined in a twodimensional SNT as described by Rweyemamu et al. (12) , with the modifications described below. Virus/serum mixtures were incubated for 1 h at 37°C. BHK 21 cells were then added at a seeding rate of 50,000 cells per microtitre tray well, and the plates were fixed and stained with 0.05% methylene blue in 10% formal saline after incubation for three days at 37°C. Duplicate tests were performed on separate days for all isolates, to determine the mean serum titre to the test virus. If the replicate titres varied by more than 0.25 Iog 10 , the test was conducted a third time and the mean value used.
The r value was calculated from the titre of the serum at 100 TCID 50 (50% tissue culture infective dose) of virus input, as determined from the two-dimensional titration using a linear regression computer program. Criteria for the interpretation of r values have been proposed by Samuel et al. (14) , as follows:
-r = 0-0.19: a highly significant serological variation from the reference vaccine strain, best countered by use of a vaccine strain with a closer relationship to the field virus.
-r = 0.20-0.39: a significant difference from the reference strain, but protection may be satisfactory if a sufficiently potent vaccine is used.
-r = 0.40-1.0: not significantly different from the reference vaccine strain as measured by the test system used.
All reference viruses and field viruses were tested against the reference A BKK/60 bovine antiserum and r values were calculated. Viruses deemed to be unrelated to A BKK/60 were tested against one or both of the A 22 reference rabbit antisera.
RESULTS AND DISCUSSION
There are 60 provinces in the 7 administrative regions outside the disease-free zone ( Fig. 1) and, during the study period, type A virus specimens were submitted to the two source laboratories from 39 provinces. A total of 82 field virus isolates from 32 (82%) of these provinces were included in the study. The isolates were from cattle (52 isolates), buffalo (12) , pigs (16) and sheep (1) . The species of origin of one isolate was unknown. The sample of virus isolates across the seven regions and over the three-year period was regarded as sufficiently representative to provide an accurate picture of the distribution of the relationships of endemic viruses to the A BKK/60 vaccine strain.
FlG.l Geographical distribution of selected foot and mouth disease virus type A isolates in Thailand between May 1986 and January 1989
The origins of the field isolates are shown in Figure 1 . The distribution of the r values obtained with the A BKK/60 bovine antiserum is shown in Figure 2 .
The r values indicated that 66 (80%) of the type A field viruses were not significantly different from A BKK/60 (r > 0.39) and could therefore be regarded as A BKK/60-related. The mean r value of this group of viruses was 0.70, with a standard deviation of 0.22. 
FIG. 2 Distribution of r values to A BKK/60 among foot and mouth disease virus type A field isolates in Thailand between May 1986 and January 1989
The twelve field viruses with r values < 0.2 to A BKK/60 cattle antiserum were tested against rabbit antisera to the A 15 and A 22 reference viruses. The results are shown in Table I . All of these viruses gave r values > 0.40 to the A2 2 antisera, and were regarded as indistinguishable from the A 22 NPT/86 reference vaccine virus. Eleven of these isolates were collected from cattle (six isolates) and pigs (five) in region 7 between 1986 and 1989, and one was taken from a buffalo in region 3 in 1987. It was noticeable that this group of viruses gave even lower r values (0.01-0.02) with the A BKK/60 rabbit antiserum than with the A BKK/60 bovine antiserum (0.11-0.19). In contrast, 33 isolates with r values > 0.4 and a mean of 0.61 (range 0.41-0.78) to A BKK/60 bovine antiserum gave a mean r value of 0.62 (range 0.29-1.09) when tested against A BKK/60 rabbit antiserum. It seems likely that the rabbit antiserum gave more specific reactions than the convalescent bovine antiserum, and more clearly distinguished those viruses which were significantly different from A 15 BKK/60.
Other isolates tested against the reference rabbit antisera showed strong reactions (r > 0.4) to both A 15 and A 22 reference antisera (see Table II ). Reactions such as these were discussed by Pereira (10), who proposed designations relating a virus to more than one strain, i.e. A 15 22 . Whether these viruses represent a distinct group, an antigenic drift of the established A l5 and A 92 field viruses, or a mixing of the two groups, will require investigation by other techniques (e.g. nucleotide sequence determination). It was noticeable that three of these isolates were from region 7 (where eleven of the twelve A 22 viruses were isolated), two from region 1 and one from region 6: significantly, regions 1 and 6 border on region 7.
The principal purposes of this study were to evaluate the suitability of the existing type A 15 vaccine strain (A BKK/60) for continued use in Thailand, and to assess the degree of strain variation among the type A viruses causing outbreaks. The criteria used for this evaluation were already established and accepted (13) . The frequency histogram (Fig. 2) showed a bimodal distribution, suggesting the presence of two distinct serological groupings of viruses, on the basis of the twodimensional SNT using bovine antiserum to A BKK/60. Sixty-six (80%) of the viruses examined were not distinguished from the A 15 reference virus A BKK/60. Twelve (15%) viruses were significantly different from this A 1S reference virus, but were related to the Thai A 22 reference virus A NPT/86. Four viruses were different from A 15 BKK/60, but not to a highly significant degree.
The data confirmed that the A 15 (A BKK/60) and A 22 (A NPT/86 and A SKL/73) reference viruses formed two serologically-distinct groups.
There was a distinct geographical localisation of viruses not related to A 15 BKK/60 but related to A 22 NPT/86, with eleven of these twelve viruses being from outbreaks in region 7. Viruses related to A 22 SKL/73 had caused outbreaks in this area of Thailand in 1979, but the continued localisation of this type A strain was unexpected, given the level of livestock movement in Thailand. In contrast, only one of the 62 viruses isolated from regions 1 to 6 was not related to A 15 BKK/60. Nine viruses from region 7 were also related to A 15 BKK/60.
It can be concluded that the current A 15 BKK/60 vaccine strain used in Thailand is capable of providing protection against the type A field strains prevalent in six of the seven regions in which outbreaks occur. In the remaining region this vaccine would be appropriate in less than 50% of outbreaks (9/20), and an A 22 vaccine would more readily confer protection against the majority of field viruses. The existing A 22 NPT/86 vaccine would be appropriate for this purpose.
The formulation of a vaccine containing both A 15 BKK/60 and A 22 NPT/86 vaccine strains might facilitate the overall control of FMD outbreaks due to type A virus in Thailand. 
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